Clinical Trials in Cleveland

Showing 6761-6780 of 19,775 trials

Boiled Peanut Oral Immunotherapy

NCT04090203

Prospective Phase 1 clinical trial providing proof of concept data on boiled peanut oral immunotherapy (OIT) for the treatment of peanut allergy in children. The investigators hypothesize that the proportion of subjects successfully desensitized with boiled peanut OIT is greater than the theoretical placebo rate of 20%.

Peanut Hypersensitivity

Alton Melton8 participantsStarted Nov 2019

Cleveland, Ohio, United States

COMPLETEDPhase 2< 1 mile

S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer

NCT02177695

The primary focus of this study is to see if looking at tumor biomarkers using a program called coexpression extrapolation or "COXEN" may predict a patient's response to chemotherapy before surgery.

Bladder Cancer

SWOG Cancer Research Network237 participantsStarted Aug 2014

Birmingham, Alabama, United States • Fairbanks, Alaska, United States • Phoenix, Arizona, United States +563 more locations

Boiled Peanut Oral Immunotherapy

S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer

Find Trials by Condition in Cleveland

A Study to Determine Dose and Regimen of Durvalumab as Monotherapy or in Combination With Pomalidomide With or Without Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma

Study of Daxdilimab (HZN-7734) for the Treatment of Systemic Lupus Erythematosus in an Open-label Extension Study

Efficacy and Safety of MK-1942 When Added to Stable Antidepressant Therapy in Participants With Treatment-Resistant Depression (TRD) (MK-1942-006)

Zephyrus I: Evaluation of Efficacy and Safety of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)

A Study to Evaluate Treatment Satisfaction With Erenumab in Participants With Migraine

A Study of CC-95251, a Monoclonal Antibody Directed Against SIRPα, in Participants With Advanced Solid and Hematologic Cancers

Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Neurotrophic Keratitis Subjects

First-in-Human Study of EOS100850 (Inupadenant) in Patients with Cancer

Long-term Safety of Lumacaftor/Ivacaftor in Participants With Cystic Fibrosis Who Are Homozygous for F508del and 12 to <24 Months of Age at Treatment Initiation

Strategies to Assist With Management of Pain

Umbilical Cord Milking in Non-Vigorous Infants

Comparative Effectiveness of Socket Casting Methods: Improving Form and Fit

Pilot Trial of the RUBI Program for Autistic Adults

Natural History Study of ENPP1 Deficiency and the Early-onset Form of ABCC6 Deficiency

Study to Evaluate Safety, Tolerability, PK and PD of DCR-PHXC in PH Type 3 Patients

A Drug-Drug Interaction Study to Evaluate the Effect of Ripretinib on the Pharmacokinetics of a CYP2C8 Probe Substrate in Patients with Advanced GIST

A Phase I/II Trial Investigating LOAd703 in Combination With Atezolizumab in Malignant Melanoma

Target Controlled Infusion Using Propofol and Remifentanil for Moderate Sedation in Dentistry